A clinical case of successful application of a new treatment method for severe COVID-19
- Authors: Samoylov A.S.1, Udalov Y.D.1, Kruglyakov N.M.1, Terekhov D.А.1, Bagzhanov G.I.1, Ochkin S.S.1
-
Affiliations:
- State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
- Issue: Vol 11, No 2 (2020)
- Pages: 93-100
- Section: Case reports
- URL: https://journals.rcsi.science/clinpractice/article/view/34529
- DOI: https://doi.org/10.17816/clinpract34529
- ID: 34529
Cite item
Full Text
Abstract
COVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of bilateral polysegmental viral pneumonia, specific complications of which may include acute respiratory distress syndrome, resulting in the respiratory failure with a high risk of death. Due to the absence of etiotropic therapy for the coronavirus infection, pathogentic treatment becomes of primary importance. We present a clinical case of a severe form of COVID-19 in a 33-year-old man to whom we administered a new method of pathogenetic treatment of this disease based on immunosuppresiive therapy followed by therapeutic plasma exchange and infusion of non-specific human immunoglobulin.
Full Text
##article.viewOnOriginalSite##About the authors
Alexander S. Samoylov
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: asamoilov@fmbcfmba.ru
ORCID iD: 0000-0002-9241-7238
SPIN-code: 3771-4848
Corresponding Member of RAS, M.D., Professor
Russian Federation, MoscowYuri D. Udalov
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: udalov@fmbafmbc.ru
ORCID iD: 0000-0002-9739-8478
SPIN-code: 7016-7538
M.D.
Russian Federation, MoscowNikolai M. Kruglyakov
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: nik160@mail.ru
ORCID iD: 0000-0001-5011-6288
SPIN-code: 5763-0498
Russian Federation, Moscow
Dmitry А. Terekhov
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: terexov-d@mail.ru
Russian Federation, Moscow
German I. Bagzhanov
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: 1380-1410@mail.ru
ORCID iD: 0000-0003-3363-5195
SPIN-code: 8981-3430
Russian Federation, Moscow
Sergey S. Ochkin
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Author for correspondence.
Email: Gazme@yandex.ru
ORCID iD: 0000-0001-8103-4963
SPIN-code: 2071-7804
Russian Federation, Moscow
References
- ВОЗ. Клиническое руководство по ведению пациентов с тяжелой острой респираторной инфекцией при подозрении на инфицирование новым коронавирусом (2019-nCoV). Временное руководство от 28 января 2020 г. WHO/nCoV/Clinical/2020.2 [интернет]. [Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance 28 January 2020. WHO/nCoV/Clinical/2020.2 [Internet]. (In Russ).] Доступно по: https://webmaster.yandex.ru/siteinfo/?site=www.rospotrebnadzor.ru. Ссылка активна на 16.05.2020.
- Роспотребнадзор. Рекомендации ВОЗ для населения в связи c распространением нового коронавируса (2019-nCoV): мифы и ложные представления [интернет]. [Rospotrebnadzor. Rekomendatsii VOZ dlya naseleniya v svyazi c rasprostraneniyem novogo koronavirusa (2019-nCoV): mify i lozhnyye predstavleniya [Internet]. (In Russ).] Доступно по: https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=13990. Ссылка активна на 16.05.2020.
- Bassetti M, Vena A, Giacobbe DR. The novel chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm. Eur J Clin Invest. 2020;50(3):e13209. doi: 10.1111/eci.13209.
- Beeching, Fletcher, Fowler, 2020, Prognosis, Case fatality rate. Available from: https://www.semanticscholar.org/paper/The-novel-Chinese-coronavirus-(2019-nCoV)-for-the-Bassetti-Vena/d3373cd7db828a91a2709ea8fbec7d6776b6f42f
- Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. doi: 10.1086/511159.
- Faqihi F, Alharthy A, Alodat M, et al. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol. Trials. 2020;21:506. doi: 10.1186/s13063-020-04454-4.
- Hua Shi, Chaomin Zhou, Pinghong He, et al. . Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection. Int J Antimicrob Agents. 2020;105974. doi: 10.1016/j.ijantimicag.2020.105974.
- Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses — a statement of the Coronavirus Study Group. bioRxiv. 2020. doi: 10.1101/2020.02.07.937862.
- Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69–71. doi: 10.5582/bst.2020.01020.
- Zhang J, Zhou L, Yang Yu, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med. 2020;8(3):e11–e12. doi: 10.1016/S2213-2600(20)30071-0.
- Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020;34(2):75–80. doi: 10.1016/j.tmrv.2020.02.003.
- Распоряжение Правительства РФ от 12 октября 2019 г. № 2406-р. [Order of the Government of the Russian Federation № 2406-r dated 2019 October 12. (In Russ).] Доступно по: https://www.garant.ru/products/ipo/prime/doc/72761778/. Ссылка активна на 20.04.2020.
- Диагностика и интенсивная терапия острого респираторного дистресс-синдрома. (In Russ).] Доступно по: http://www.far.org.ru/recomendation